Trial Profile
A Study to Evaluate the Safety and Efficacy of S-1 plus Split Cisplatin in Patients with Advanced Gastric Cancer (AGC)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Dec 2015
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 07 Dec 2015 New trial record